BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21112205)

  • 21. Solid-state NMR spectroscopic investigation of Aβ protofibrils: implication of a β-sheet remodeling upon maturation into terminal amyloid fibrils.
    Scheidt HA; Morgado I; Rothemund S; Huster D; Fändrich M
    Angew Chem Int Ed Engl; 2011 Mar; 50(12):2837-40. PubMed ID: 21387500
    [No Abstract]   [Full Text] [Related]  

  • 22. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic analysis of beta-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing.
    Hu WP; Chang GL; Chen SJ; Kuo YM
    J Neurosci Methods; 2006 Jun; 154(1-2):190-7. PubMed ID: 16457893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR reveals two-step association of Congo Red to amyloid β in low-molecular-weight aggregates.
    Pedersen MØ; Mikkelsen K; Behrens MA; Pedersen JS; Enghild JJ; Skrydstrup T; Malmendal A; Nielsen NC
    J Phys Chem B; 2010 Dec; 114(48):16003-10. PubMed ID: 21077638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregation of Alzheimer amyloid beta peptide (1-42) on the multivalent sulfonated sugar interface.
    Fukuda T; Matsumoto E; Onogi S; Miura Y
    Bioconjug Chem; 2010 Jun; 21(6):1079-86. PubMed ID: 20486703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface plasmon resonance spectroscopy in determination of the interactions between amyloid beta proteins (Abeta) and lipid membranes.
    Hou X; Small DH; Aguilar MI
    Methods Mol Biol; 2010; 627():225-35. PubMed ID: 20217625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-dependent kinetics of copper ions binding to amyloid-β peptide.
    Bin Y; Chen S; Xiang J
    J Inorg Biochem; 2013 Feb; 119():21-7. PubMed ID: 23174653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TANGO-Inspired Design of Anti-Amyloid Cyclic Peptides.
    Lu X; Brickson CR; Murphy RM
    ACS Chem Neurosci; 2016 Sep; 7(9):1264-74. PubMed ID: 27347598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of surface-functionalized nanoparticles on the elongation phase of beta-amyloid (1-40) fibrillogenesis.
    Chan HM; Xiao L; Yeung KM; Ho SL; Zhao D; Chan WH; Li HW
    Biomaterials; 2012 Jun; 33(18):4443-50. PubMed ID: 22459190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.
    Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
    J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanical unbinding of abeta peptides from amyloid fibrils.
    Raman EP; Takeda T; Barsegov V; Klimov DK
    J Mol Biol; 2007 Oct; 373(3):785-800. PubMed ID: 17868685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
    Milojevic J; Esposito V; Das R; Melacini G
    J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface plasmon resonance for the label-free detection of Alzheimer's β-amyloid peptide aggregation.
    Palladino P; Aura AM; Spoto G
    Anal Bioanal Chem; 2016 Jan; 408(3):849-54. PubMed ID: 26558762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface plasmon resonance biosensors for simultaneous monitoring of amyloid-beta oligomers and fibrils and screening of select modulators.
    Yi X; Feng C; Hu S; Li H; Wang J
    Analyst; 2016 Jan; 141(1):331-6. PubMed ID: 26613550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
    Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
    J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time surface plasmon resonance imaging measurements for the multiplexed determination of protein adsorption/desorption kinetics and surface enzymatic reactions on peptide microarrays.
    Wegner GJ; Wark AW; Lee HJ; Codner E; Saeki T; Fang S; Corn RM
    Anal Chem; 2004 Oct; 76(19):5677-84. PubMed ID: 15456285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide concentration alters intermediate species in amyloid β fibrillation kinetics.
    Garvey M; Morgado I
    Biochem Biophys Res Commun; 2013 Apr; 433(3):276-80. PubMed ID: 23454128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
    Ohnishi S; Koide A; Koide S
    J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.